Atrial Fibrillation (AF) Market is valued at USD 5689.8 Million in 2018 and expected to reach USD 11229.7 Million by 2025 with the CAGR of 10.2 % over the forecast period. Increasing preference of catheter ablation for cardiac arrhythmia treatment and increasing prevalence of obesity, hypertension in the population are the major driving factors for the growth of the Global Atrial Fibrillation Market.
Atrial fibrillation is a rapid or irregular rhythm of the heart that increases the risk of heart, stroke, and other complications, such as discomfort (Angina), pressure, or chest pain which may lead to congestive heart failure. Catheter ablation is one of useful treatments of abnormal heart rhythm, specifically when medications are ineffective. It is a low-risk minimal invasive procedure for cardiac arrhythmias treatment. The catheter ablation device removes the faulty heart tissues that cause irregular heart rhythms. Catheter ablation has rendered 95.0% of success rate in treatment of cardiac arrhythmias. Around 50,000 catheter ablation procedures are performed each year in Germany. Atrial Fibrillation market is witnessing a significant growth owing to the increasing adoption of catheter ablation for cardiac arrhythmia treatment.
Get Sample Copy of This Premium Report@ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=57375&RequestType=Sample
Global atrial fibrillation market report is segmented on the basis of device, end-user and region. Based upon device, atrial fibrillation market is classified into surgical devices and non-surgical devices. Surgical devices segment is further divided into maze surgery, microwave based catheter ablation, laser based catheter ablation, catheter ablation, radiofrequency catheter ablation, cryoablation, and others. Non-surgical devices segment is further divided into electric cardio version, conventional diagnostic catheters, diagnostic catheters, mapping and recording systems, advanced diagnostic catheters, cardiac monitors, access devices, left atrial appendage and closure devices and others. By end-user, atrial fibrillation market is classified into hospitals, clinics, ambulatory surgery centers and others.
The regions covered in this atrial fibrillation market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of packaging testing is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Key Players for Atrial Fibrillation Market Reports-
Some of the key players in global Atrial Fibrillation market are Boston Scientific Corporation, Abbott, Biosense Webster, Inc., St. Jude Medical, Inc., Siemens Healthcare, Medtronic plc, Koninklijke Philips N.V. and AtriCure, Inc.
Abbott Expanded Cardiac Arrhythmias Portfolio in India with Launch of Advanced Mapping Catheter
on 11 June 2019: Abbott launched the HD mapping Catheter, which is sensor enabled in India. That product received the US FDA clearance at last year in May. The catheter employs a new design that allowed physician to saw things differently, captured and analyzed data in a novel manner to create highly detailed maps of the heart that better differentiate healthy from unhealthy tissue. The new mapping catheter builds upon Abbott’s innovative products designed to improve how physician performed cardiac ablation procedure, including cardiac mapping system and treatment catheter. Launched of that product had further expanded Abbott’s comprehensive portfolio of mapping and treatment catheter. Combined, the portfolio has helped improved how physicians approach the treatment of complex of arrhythmias and atrial fibrillation and introduced a new level of innovation into electrophysiology market. That catheter has been used in 20 countries since European launched and in the US since US FDA approval last year.
Request for Methodology @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=57375
Unfavorable Preference to Pharmaceutical Interventions (Drugs) Over AF Treatment Devices
Increasing prevalence of obesity and hypertension among aging population, reduce mortality rate and favorable outcomes of the atrial fibrillation are the factors expected to drive the growth of global atrial Fibrillation market. In addition, the rise in people suffering from high blood pressure, and valvular heart disease due to the rheumatic fever are some of the most common risk factors for atrial fibrillation. Furthermore, atrial fibrillation device is an alternative to long term oral anticoagulants among non-valvular atrial fibrillation (NVAF) patients, eliminate the use of long-term warfarin and reduce the risk of heart bleeding and strokes which is further anticipated to fuel the growth of global Atrial Fibrillation market. However, alternative to atrial fibrillation such as drug therapy, catheter related complications and high cost of minimally invasive ablation procedures may hamper the growth of atrial Fibrillation market. Moreover, growing availability of alternative technologies coupled with growing adoption of minimally invasive surgeries is expected to offer opportunities for growth of the global atrial Fibrillation market.
North America is Expected to Dominate the Global Atrial Fibrillation Market.
By region, the global atrial Fibrillation market is segmented into North America, Europe, Asia Pacific, and the Middle East & Africa. Geographically, North America is expected to account for the highest market share of this market within the forecast period. This is mainly attributed to the presence of refined healthcare infrastructure and high adoption rate of highly advanced technologies in North American countries such as U.S., Canada, and Mexico. In addition, emergent markets such as Mexico have witnessed significant investments by government and vendors. Asia-Pacific is projected to be the fastest growing region during the forecast period due to its vast population and different age groups being susceptible to cardiac diseases. In addition, improvement in healthcare infrastructure and increasing healthcare expenditure in the emerging markets (such as India and China) are also augmenting the market growth in this region.
Key Benefits for Atrial Fibrillation Market Reports –
- Global market report covers in depth historical and forecast analysis.
- Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
- Global market report helps to identify opportunities in marketplace.
- Global market report covers extensive analysis of emerging trends and competitive landscape.
Get Full information of This Report@ https://brandessenceresearch.biz/Lifesciences-and-Healthcare/Atrial-Fibrillation-Market-Growth/Summary
Atrial Fibrillation Market Segmentation: –
By Devices (Surgical Devices, Non-Surgical Devices), By End-User (Hospitals, Clinics, Ambulatory Surgery Centers, Others)
As a leading market research reseller, we help businesses exploit market intelligence and leverage the in-depth analysis of market research to devise strategies in a competitive market. Our expertise in business domains helps us to curate and aggregate market research reports that offer a laser-like focus on the targeted segments. A slice of the market share is a hard won battle, and it takes the power of actionable insights to help businesses take timely decisions. The ‘need of the hour’ is inputs that are relevant and on time.
Contact us at: +44-2038074155 or mail us at firstname.lastname@example.org
Website : https://brandessenceresearch.biz